Welcome to episode no. 39 (November 2025) of Diabetes Care "On Air"—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the November 2025 issue of Diabetes Care and beyond. 3:00 Alice is joined by Inês Barroso, PhD, MSc, Professor of Diabetes at the University of Exeter Medical School. She is the senior author of the article "Undiagnosed G6PD Deficiency in Black and Asian Individuals Is Prevalent and Contributes to Health Inequalities in Type 2 Diabetes Diagnosis and Complications," available for free at doi.org/10.2337/dc25-0556. 22:35 Mike speaks with Kirsten Nørgaard, MD, DMSc, a Clinical Professor of Medicine in the Steno Diabetes Center at the University of Copenhagen in Denmark. She is the senior author of the article "Upper-Limb Complications in Diabetes: A Narrative Review," available for free at doi.org/10.2337/dci25-0012. 34:40 In the "Diabetes Care Rapid Exchange," Alice and Mike wrap up the episode by reviewing several interesting articles in the November 2025 issue of Diabetes Care. Studies highlighted in this segment include: Rossing et al. Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis doi.org/10.2337/dc25-0472 Nash et al. Reimagining Acute Diabetes Care: Insights From the Victorian Virtual Emergency Department doi.org/10.2337/dc25-0852 Pop-Busui et al. Differences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort doi.org/10.2337/dc25-1087 Ayati et al. Quantifying Barriers to Diabetic Eye Screening: A Two-Center Study at the University of California doi.org/10.2337/dc25-0951 Agarwal et al. Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial) doi.org/10.2337/dc25-1673 Applebaum et al. Risk Factors and Consequences of Lapses in Proliferative Diabetic Retinopathy Care in a National Cohort doi.org/10.2337/dc25-1202 To learn more about Diabetes Care, please visit diabetesjournals.org/care. Interested in submitting cover art to the journal? Please visit https://diabetesjournals.org/care/pages/submit_a_cover_image.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related